Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis

Background: Fatigue is a typical consequence of cancer that can affect one’s quality of life (QOL). The goal of this review is to provide comprehensive data on the impact of fatigue on QOL of cancer patients. Methods: An electronic data search in Web of Science, SCOPUS, and PubMed for relevant paper...

Full description

Bibliographic Details
Published in:Asian Pacific Journal of Cancer Prevention
Main Author: Muthanna F.M.S.; Hassan B.A.R.; Karuppannan M.; Ibrahim H.K.; Mohammed A.H.; Abdulrahman E.
Format: Review
Language:English
Published: Asian Pacific Organization for Cancer Prevention 2023
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150963734&doi=10.31557%2fAPJCP.2023.24.3.769&partnerID=40&md5=ab06e294cbc1561636fb55a3b72b0bba
id 2-s2.0-85150963734
spelling 2-s2.0-85150963734
Muthanna F.M.S.; Hassan B.A.R.; Karuppannan M.; Ibrahim H.K.; Mohammed A.H.; Abdulrahman E.
Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
2023
Asian Pacific Journal of Cancer Prevention
24
3
10.31557/APJCP.2023.24.3.769
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150963734&doi=10.31557%2fAPJCP.2023.24.3.769&partnerID=40&md5=ab06e294cbc1561636fb55a3b72b0bba
Background: Fatigue is a typical consequence of cancer that can affect one’s quality of life (QOL). The goal of this review is to provide comprehensive data on the impact of fatigue on QOL of cancer patients. Methods: An electronic data search in Web of Science, SCOPUS, and PubMed for relevant papers; those written in English; those reporting quantitative data; and those including more than one hundred patients who received just chemotherapy were included. Studies involving participants that received other kinds of anti-neoplastic therapies were excluded. Results: A total of 35 papers published between January 2000 and December 2021 were retrieved from the search databases of which (11612 patients) met the inclusion criteria. Findings showed that fatigue negatively affected QOL with a pooled prevalence of 49% (95% CI; 25.00-74.00) and the significant heterogeneity between articles was (I2=98%, P <0.001). Further, breast cancer contributed to the majority of selected articles with about 55 % (95%CI; 9:00-94:00), followed by cancer (unspecified) 44% (95%CI; 5:00 – 92:00). Most studies (71%) (95%CI; 4:00 – 99:00) used the brief fatigue inventory (BFI) tool to assess severity of fatigue and 39% (95%CI; 17:00 -68:00) employed the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire to evaluate QOL among cancer survivors. Conclusion: The prevalence of fatigue in cancer patients is high and fatigue has a negative impact on QOL of cancer patients receiving chemotherapy. Directionality, fatigue needs to be addressed and treated properly for better improvement of health status and QOL in cancer patients © 2023,Asian Pacific Journal of Cancer Prevention. All Rights Reserved.
Asian Pacific Organization for Cancer Prevention
15137368
English
Review
All Open Access; Gold Open Access
author Muthanna F.M.S.; Hassan B.A.R.; Karuppannan M.; Ibrahim H.K.; Mohammed A.H.; Abdulrahman E.
spellingShingle Muthanna F.M.S.; Hassan B.A.R.; Karuppannan M.; Ibrahim H.K.; Mohammed A.H.; Abdulrahman E.
Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
author_facet Muthanna F.M.S.; Hassan B.A.R.; Karuppannan M.; Ibrahim H.K.; Mohammed A.H.; Abdulrahman E.
author_sort Muthanna F.M.S.; Hassan B.A.R.; Karuppannan M.; Ibrahim H.K.; Mohammed A.H.; Abdulrahman E.
title Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
title_short Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
title_full Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
title_fullStr Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
title_full_unstemmed Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
title_sort Prevalence and Impact of Fatigue on Quality of Life (QOL) of Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
publishDate 2023
container_title Asian Pacific Journal of Cancer Prevention
container_volume 24
container_issue 3
doi_str_mv 10.31557/APJCP.2023.24.3.769
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150963734&doi=10.31557%2fAPJCP.2023.24.3.769&partnerID=40&md5=ab06e294cbc1561636fb55a3b72b0bba
description Background: Fatigue is a typical consequence of cancer that can affect one’s quality of life (QOL). The goal of this review is to provide comprehensive data on the impact of fatigue on QOL of cancer patients. Methods: An electronic data search in Web of Science, SCOPUS, and PubMed for relevant papers; those written in English; those reporting quantitative data; and those including more than one hundred patients who received just chemotherapy were included. Studies involving participants that received other kinds of anti-neoplastic therapies were excluded. Results: A total of 35 papers published between January 2000 and December 2021 were retrieved from the search databases of which (11612 patients) met the inclusion criteria. Findings showed that fatigue negatively affected QOL with a pooled prevalence of 49% (95% CI; 25.00-74.00) and the significant heterogeneity between articles was (I2=98%, P <0.001). Further, breast cancer contributed to the majority of selected articles with about 55 % (95%CI; 9:00-94:00), followed by cancer (unspecified) 44% (95%CI; 5:00 – 92:00). Most studies (71%) (95%CI; 4:00 – 99:00) used the brief fatigue inventory (BFI) tool to assess severity of fatigue and 39% (95%CI; 17:00 -68:00) employed the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire to evaluate QOL among cancer survivors. Conclusion: The prevalence of fatigue in cancer patients is high and fatigue has a negative impact on QOL of cancer patients receiving chemotherapy. Directionality, fatigue needs to be addressed and treated properly for better improvement of health status and QOL in cancer patients © 2023,Asian Pacific Journal of Cancer Prevention. All Rights Reserved.
publisher Asian Pacific Organization for Cancer Prevention
issn 15137368
language English
format Review
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1809678479474556928